Xiaogang Zhang
No.1500 Zhouyuan Road
Pudong, 201318, China
Pudong, 201318, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Corilagin inhibits angiotensin II-induced atrial fibrosis and fibrillation in mice through the PI3K-Akt pathway.
Journal: Iranian journal of basic medical sciences
Published: June 23, 2023
Prospective prescription review system correlated with more rational PPI medication use, better clinical outcomes and reduced PPI costs: experience from a retrospective cohort study.
Journal: BMC health services research
Published: January 23, 2023
Stachydrine ameliorates hypoxia reoxygenation injury of cardiomyocyte via enhancing SIRT1-Nrf2 pathway.
Journal: Journal of cardiothoracic surgery
Published: August 04, 2022
Interleukin-11 Is Elevated in Patients with Atrial Fibrillation, Correlates with Serum Fibrosis Markers, and Represents a Therapeutic Target for Atrial Fibrosis.
Journal: Cerebrovascular diseases (Basel, Switzerland)
Published: August 04, 2022
Integrating Multidisciplinary Individualized Medication Recommendations Into the Traditional Pharmacists' Consultation Method: A Retrospective Study Using Propensity Score Matching Analysis.
Journal: Inquiry : a journal of medical care organization, provision and financing
Published: May 25, 2022
Prediction model based on machine learning for short- and long-term adverse events in left atrial appendage closure.
Journal: Journal of thoracic disease
Published: March 22, 2022
Inhibition of FABP4 attenuates cardiac fibrosis through inhibition of NLRP3 inflammasome activation.
Inhibition of FABP4 attenuates cardiac fibrosis through inhibition of NLRP3 inflammasome activation.
Journal: Iranian journal of basic medical sciences
Published: March 20, 2022
Delineating the conformational landscape and intrinsic properties of the angiotensin II type 2 receptor using a computational study.
Journal: Computational and structural biotechnology journal
Published: March 09, 2022
LOXL2 silencing suppresses angiotensin II-induced cardiac hypertrophy through the EMT process and TGF-β1/Smad3/NF-κB pathway.
Journal: Iranian journal of basic medical sciences
Published: January 29, 2022
ANGPTL4 Attenuates Ang II-Induced Atrial Fibrillation and Fibrosis in Mice via PPAR Pathway.
Journal: Cardiology research and practice
Published: March 06, 2021
Emergency hospitalizations for adverse drug events in China: Clinical pharmacists' approach to assessment and categorization.
Journal: Pharmacoepidemiology and drug safety
Published: July 17, 2020
Last Updated: 09/26/2026